NEW YORK BLOOD CENTER, INC.

New York Blood Center, Inc. specializes in the manufacturing and supply of human blood and blood-derived biological products, including plasma, red blood cells, platelets, and related therapeutic components, under strict regulatory and quality control standards. Their technical expertise lies in aseptic processing, cold chain logistics, pathogen reduction technologies, and compliance with FDA and AABB guidelines for biological product manufacturing. The organization demonstrates deep proficiency in end-to-end blood product lifecycle management—from donor screening and collection to processing, storage, and just-in-time distribution—ensuring safety, sterility, and readiness for critical clinical use. Their specialization in non-diagnostic biological manufacturing positions them as a trusted provider of life-sustaining cellular and plasma-based therapeutics for high-acuity healthcare environments. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, delivering essential blood products and associated services to VA medical centers nationwide. This partnership reflects a proven ability to meet the VA’s operational demands for trauma care, surgical support, and chronic disease management through reliable, mission-critical supply chain performance. The recurring nature of these awards indicates a trusted vendor status grounded in consistent quality, regulatory adherence, and responsive logistics. Their primary industry focus is biological product manufacturing (NAICS 325414), a niche sector requiring specialized facilities, validated processes, and stringent documentation under cGMP standards. The contractor’s market positioning centers on serving federal healthcare systems that require uninterrupted access to allogeneic blood products and associated services, distinguishing them from diagnostic or pharmaceutical manufacturers. As a non-profit entity structured under 8H (Other Not-for-Profit Organization), New York Blood Center, Inc. operates from Kansas City, MO, with a federal market presence anchored in direct support of veteran healthcare infrastructure. While no formal government certifications are listed, their compliance with federal biological product regulations and consistent performance for the VA underscores their credibility as a mission-aligned supplier in the federal biologics sector.